Latest Conference Articles

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

November 19th 2025

The conclusion of this interview with Sanjay Konagurthu focuses on simulations and calculations that go beyond simple screening.

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

November 18th 2025

AAPS

Sanjay Konagurthu of Thermo Fisher Scientific discusses how AI and ML can help solve the dilemma of poor solubility.

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

November 17th 2025

Mechanistic models and hypothesis-driven strategies generate optimized efficient solutions for drug development, says Catalent’s Nathan Bennette at AAPS PharmSci 360.

At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development

November 14th 2025

AAPS

Corey Bloom of Lonza outlines major points from his AAPS presentation, from drug delivery technology selection to the importance of CDMO partnerships.

Achieving a Personalized Digital Control Arm for Preclinical Drug Evaluation

November 13th 2025

At AAPS PharmSci 360 2025, Elly Zhou says digital twins helped forecast the effects of drugs on human drugs via a digital control arm.

How 3D-Printed Tablets Can Optimize IgA Nephropathy Treatment

November 12th 2025

At AAPS PharmSci 360, Xialing Li, PhD, says 3D-printed budesonide tablets achieve precise, delayed delivery to the ileum for IgA nephropathy, lowering in vivo variability.

AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting

November 11th 2025

At AAPS PharmSci 360, Xuanzi Zhou says digital twins accurately predict ex vivo lung function, revealing therapeutic effects missed by conventional preclinical drug testing.

Defining An Agitation Model for Early-Stage, High Concentration Biologics Formulation Development

November 11th 2025

AAPS

Siddhant Sojitra, Alexion, defines in an AAPS PharmSci 360 2025 presentation an agitation model to reliably test stability for early-stage biologics.

Using A Streamlined Workflow to Identify Particulates in Biologic Drugs

November 11th 2025

In a poster presentation at AAPS PharmSci 360, Eda Fenercioglu, a scientist at Pfizer, outlines a streamline workflow for identifying and mitigating visible particles in biologic drugs.

AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis

November 11th 2025

Pharmaceutical Technology® spoke with Steve Lowes, senior director of Scientific Affairs at IQVIA Laboratories, ahead of AAPS PharmSci 360 to discuss some of the unique instruments used to conduct bioanalysis.